Drinking coffee regularly may protect the liver and even slow the progression of liver disease, according to a comprehensive new review published in Biochemical Pharmacology. The review compiles decades of epidemiological, clinical, and experimental data, shedding light on how coffee helps prevent scarring, inflammation, and long-term liver damage.
Researchers found that coffee’s blend of bioactive compounds, including chlorogenic acid and polyphenols, plays a major role in reducing the risk of fibrosis, cirrhosis, and hepatocellular carcinoma. These compounds demonstrate antioxidant, anti-inflammatory, and antifibrotic effects at a molecular level.
“Coffee contains specific compounds that may help protect liver cells and improve their function,” said Michelle Routhenstein, MS, RD, CDCES, CDN, a preventive cardiology dietitian at EntirelyNourished. “Its antioxidant effects may reduce oxidative stress, which is a key driver of liver damage.”
The review analyzed data on several liver conditions, confirming that coffee consumption is linked to a lower risk of:
Beyond the liver, coffee supports gut microbiome balance and positively impacts metabolism. Researchers noted that coffee promotes beneficial gut bacteria and modulates epigenetic factors that influence liver health.
Experts suggest that up to 400 mg of caffeine per day (about three to four cups) is generally safe for most adults. However, people with caffeine sensitivity, cardiovascular disease, or anxiety disorders may need to limit their intake. Consuming more than five cups daily can raise LDL (“bad”) cholesterol levels and potentially contribute to dyslipidemia.
Since liver and heart health are connected, moderate coffee consumption may also support cardiovascular health. However, healthcare providers recommend individualizing coffee intake, especially for patients with pre-existing heart conditions or those on medications such as beta blockers or blood thinners.
The findings highlight coffee as a simple, low-cost dietary intervention with major public health potential. The review’s insights into molecular pathways could also open the door for new clinical trials and targeted therapies for chronic liver diseases.
CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for expert tips, health updates, and the latest medical research straight to your phone.